Malignant New Growth of the Brain
The VA rates Malignant New Growth of the Brain under Diagnostic Code 8002 across 2 severity levels, from 30% to 100%. At 100%, a veteran with no dependents receives $3,938.58 per month, tax-free (2026 rates); dependents add to that.
Rating schedule — DC 8002 at a glance
- Minimum rating
- 30%
- Maximum rating
- 100%
- Rating tiers
- 2
- CFR section
- § 4.124a
- Body system
- Neurological Conditions
- Secondary conditions
- 0
Lowest schedular rating available
Full schedular disability
30%, 100%
Part 4 rating schedule
None mapped
What are the VA rating criteria for Malignant New Growth of the Brain?
| Rating | Criteria |
|---|---|
| 30% | Minimum rating |
| 100% | Malignant |
“Malignant”
Common Questions About Malignant New Growth of the Brain VA Ratings
What is the VA rating range for Malignant New Growth of the Brain?
The VA rates Malignant New Growth of the Brain under Diagnostic Code 8002 at 30%, 100%. The minimum 30% rating requires: Minimum rating. The maximum 100% rating requires: Malignant.
Which 38 CFR diagnostic code does the VA use for Malignant New Growth of the Brain?
The VA rates Malignant New Growth of the Brain under Diagnostic Code (DC) 8002, governed by 38 CFR 38 CFR § 4.124a. The diagnostic code establishes the specific rating tiers and severity criteria the VA examiner applies.
What is the difference between a 30% and a 100% rating for Malignant New Growth of the Brain?
A 30% rating requires: Minimum rating. A 100% rating requires: Malignant. The difference typically reflects the frequency, severity, or functional impact of the condition as documented in medical records and C&P examination findings.
Can Malignant New Growth of the Brain qualify for TDIU?
Yes — a 100% rating for Malignant New Growth of the Brain alone meets the single-disability threshold for TDIU (38 CFR § 4.16). If the condition prevents substantially gainful employment, the veteran is compensated at the 100% rate without a schedular 100% rating.
What evidence supports a higher rating for Malignant New Growth of the Brain?
The key evidence for Malignant New Growth of the Brain is documentation of how the condition affects daily functioning. For neurological conditions, nerve conduction studies, EMG results, and documentation of complete vs incomplete paralysis distinguish the rating tiers. A nexus letter from a qualified medical professional linking the current severity to service is essential for contested claims.
What happens at the C&P exam for Malignant New Growth of the Brain?
The C&P examiner uses a Neurological Conditions DBQ and evaluates your condition against the DC 8002 rating criteria. The examiner tests reflexes, sensation, and motor function. If nerve damage is suspected, EMG or nerve conduction studies may be ordered. Distinguish between complete and incomplete paralysis — the rating difference is significant.
Get a Personalized Rating Analysis
VeteranHQ evaluates your symptoms against the exact 38 CFR criteria, identifies secondary conditions, and shows what evidence you need to support a higher rating.
Discover Your Benefits